Takahashi M, Tokunaga E, Mori J, Tanizawa Y, et al. Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Breast Cancer 2021 Oct 18. pii: 10.1007/s12282-021-01295.
PMID: 34661821